Our study presents compelling evidence suggesting a significant increase in KLF4 expression in H9C2 cells subjected to H/R treatment, indicating its potential role as a pro-inflammatory mediator in myocardial infarction. The gene discussed is KLF4; the disease is myocardial infarction.